Allogeneic hematopoietic stem cell transplantation (HSCT) is considered standard of care in eligible patients with acute myeloid leukemia (AML) and intermediate or adverse risk in first complete remission (CR) as …
Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.
Copyright ©️ 2025 Daily Transplant News | All rights reserved.
